Harrow, Inc. (HROW:NASDAQ) closed at $28.44 on October 23, 2026, up 1.03% on the day. The stock trades 48.1% below its 52-week high of $54.85 and 5.5% above its 52-week low of $26.96. Over the past year, it lost 26.2%. Harrow, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 23, 2025, HROW closed higher on 120 days (48%). Its best day was November 11, 2025 (+13.47%) and its worst was March 3, 2026 (-27.95%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
Imprimis Pharmaceuticals Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.
Find more stocks like HROW with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.